Journal of Clinical Oncology

70-gene signature not cost-effective in breast cancer

(HealthDay)—For patients with node-negative breast cancer (NNBC), the 70-gene signature is unlikely to be cost-effective for guiding adjuvant chemotherapy decision making, according to a study published ...

Oct 18, 2014
popularity 3 / 5 (2) | comments 0

Obesity tied to higher cancer risk for CRC survivors

(HealthDay)—Colorectal cancer (CRC) patients who are overweight or obese when diagnosed appear to face a slightly higher risk for developing a second weight-related cancer, according to research published ...

Oct 01, 2014
popularity not rated yet | comments 0